The Use of Impella 5.5 Reduces Pulmonary Vascular Resistance as Bridge to Heart Transplant in a Pediatric Patient.

IF 3.1 3区医学 Q2 ENGINEERING, BIOMEDICAL

ASAIO Journal Pub Date : 2025-03-01 Epub Date: 2024-06-19 DOI:10.1097/MAT.0000000000002256

Bradley Oelkers, Erin Schumer, Andrea N Lambert, Bahaaldin Alsoufi, Deborah Kozik, Sarah J Wilkens

引用次数: 0

Abstract

This case report explores the successful use of the Impella 5.5 (Abiomed Inc., Danvers, MA) device in a 22 kg, 0.89 body surface area (BSA) pediatric patient with longstanding dilated cardiomyopathy and elevated pulmonary vascular resistance. The article details the device selection, management, and outcome demonstrating the feasibility and potential benefits of the Impella 5.5 as a device within the pediatric population.

查看原文本刊更多论文

使用 Impella 5.5 降低肺血管阻力，为儿科患者的心脏移植架起桥梁。

本病例报告探讨了 Impella 5.5（Abiomed 公司，马萨诸塞州丹佛斯）设备在一名体重 22 公斤、体表面积 (BSA) 0.89 的长期扩张型心肌病和肺血管阻力升高的儿科患者身上的成功应用。文章详细介绍了设备的选择、管理和结果，证明了 Impella 5.5 作为儿科设备的可行性和潜在优势。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ASAIO Journal 医学-工程：生物医学

CiteScore

6.60

自引率

7.10%

发文量

651

审稿时长

4-8 weeks

期刊介绍： ASAIO Journal is in the forefront of artificial organ research and development. On the cutting edge of innovative technology, it features peer-reviewed articles of the highest quality that describe research, development, the most recent advances in the design of artificial organ devices and findings from initial testing. Bimonthly, the ASAIO Journal features state-of-the-art investigations, laboratory and clinical trials, and discussions and opinions from experts around the world. The official publication of the American Society for Artificial Internal Organs.